Evidence map›Paper›PMID 32595279›Full record

ArticleInfectious diseases2020

Efficacy of Single Dose Ivermectin Against

Tadesse Hailu, Endalkachew Nibret, Arancha Amor, Abaineh Munshea, Melaku Anegagrie

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. High Efficacy of Ivermectin for Strongyloidiasis Treatment.The American journal of tropical medicine and hygiene · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Helminthologia · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Tadesse HailuCollege of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.ORCID https://orcid.org/0000-0003-0116-1888
Endalkachew NibretDepartment of Biology, Science College, Bahir Dar University, Bahir Dar, Ethiopia.
Arancha AmorMundo Sano Foundation, Institute of Health Carlos III, Madrid, Spain.
Abaineh MunsheaDepartment of Biology, Science College, Bahir Dar University, Bahir Dar, Ethiopia.ORCID https://orcid.org/0000-0002-1469-2189
Melaku AnegagrieMundo Sano Foundation, Institute of Health Carlos III, Madrid, Spain.
Bahir Dar University · ETInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIvermectin has been proven to be highly effective against

objectiveThis study aimed to evaluate the efficacy of single dose ivermectin against

methodsStool sample was collected from April 2019 to December 2019 among 844 school children and screened by formol ether concentration, spontaneous tube sedimentation, Baermann concentration, and agar plate techniques. Single oral dose (200 μg/kg) ivermectin was given to 101

resultsOf the total 92

conclusionSingle dose ivermectin is an effective dose in uncomplicated chronic strongyloidiasis.

Indexed as

cure rateefficacyivermectinStrongyloides stercoralis

Identifiers

PMID32595279
PMCPMC7297470
OpenAlexW3034210581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.